Supplemental Table 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Authors

Shuya Kandori (ORCID: https://orcid.org/0000-0003-4621-8470)
Hiromichi Sakurai
Bunpei Isoda (ORCID: https://orcid.org/0009-0008-6483-3032)
Hiromitsu Negoro (ORCID: https://orcid.org/0000-0003-1144-2755)
Bryan J. Mathis (ORCID: https://orcid.org/0000-0002-9879-8289)
Takamitsu Inoue (ORCID: https://orcid.org/0000-0002-1362-4344)
Akira Joraku
Tomoki Ishida
Masanobu Shiga (ORCID: https://orcid.org/0000-0001-8610-0149)
Hiroyuki Nishiyama (ORCID: https://orcid.org/0000-0001-7423-596X)
Masahiro Iinuma (ORCID: https://orcid.org/0000-0003-1777-1525)
Manabu Komine
Masakazu Tsutsumi
Shigeru Takahashi (ORCID: https://orcid.org/0009-0002-0028-1466)
K Tanaka
Akifumi Omiya
Kotoe Matsuda
Jun Miyazaki (ORCID: https://orcid.org/0000-0002-3618-0432)

Publication Details

Published: 2025-09-19
DOI: https://doi.org/10.1158/2767-9764.30162544
Primary Topic: Renal cell carcinoma treatment
Type: article
Field-Weighted Citation Impact: 0.00

Supplemental Table 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Shuya Kandori, Hiromichi Sakurai, Bunpei Isoda, Hiromitsu Negoro, Bryan J. Mathis, Takamitsu Inoue, Akira Joraku, Tomoki Ishida, Masanobu Shiga, Hiroyuki Nishiyama, Masahiro Iinuma, Manabu Komine, Masakazu Tsutsumi, Shigeru Takahashi, K Tanaka, Akifumi Omiya, Kotoe Matsuda, Jun Miyazaki

September 19, 2025article en

Supplemental Table 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Authors

Publication Details

Supplemental Table 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Supplemental Table 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.